Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
28 APS antibodies: managing patients when laboratory scenarios don’t fit guidelinesLupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A15-A16 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.28Full text available |
|
2 |
Material Type: Article
|
I39 Management of refractory APSLupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A4-A4 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.7Full text available |
|
3 |
Material Type: Article
|
LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndromeLupus science & medicine, 2023-07, Vol.10 (Suppl 1), p.A34-A34 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-KCR.42Full text available |
|
4 |
Material Type: Article
|
P1 Intra-renal involvement in primary antiphospholipid antibodies syndrome: data from two Italian centersLupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A42-A43 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.55Full text available |
|
5 |
Material Type: Article
|
Neurosurgical emergencies during pregnancy – Management dilemmasSurgical neurology international, 2023-04, Vol.14, p.151, Article 151Copyright: © 2023 Surgical Neurology International 2023 ;ISSN: 2229-5097 ;EISSN: 2152-7806 ;DOI: 10.25259/SNI_1076_2022Full text available |
|
6 |
Material Type: Article
|
How to HIIT while pr T while pregnant? The pr egnant? The protocol char ocol characteristics and acteristics and effects of high intensity interval training implemented during pregnancy – A systematic reviewBaltic journal of health and physical activity, 2022-03, Vol.14 (1), p.Article 1 [Peer Reviewed Journal]EISSN: 2080-9999 ;DOI: 10.29359/BJHPA.14.1.01Full text available |
|
7 |
Material Type: Article
|
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinomaOncotarget, 2016-06, Vol.7 (24), p.36366-36381Attribution ;Copyright: © 2016 Ahmed et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.8917 ;PMID: 27119352Full text available |
|
8 |
Material Type: Article
|
How to HIIT while pregnant? The protocol characteristics and effects of high intensity interval training implemented during pregnancy – A systematic reviewBaltic journal of health and physical activity, 2022-01, Vol.14 (1), p.Article-1 [Peer Reviewed Journal]ISSN: 2080-9999 ;EISSN: 2080-9999 ;DOI: 10.29359/BJHPA.14.1.01Full text available |
|
9 |
Material Type: Article
|
Physical Activity during Pregnancy may Mitigate Adverse Outcomes Resulting from COVID-19 and Distancing Regulations: Perspectives of Prenatal Healthcare Providers in the Southern Region of the United StatesInternational journal of exercise science, 2021, Vol.14 (3), p.1138-1150 [Peer Reviewed Journal]2021 ;ISSN: 1939-795X ;EISSN: 1939-795X ;PMID: 35096236Full text available |
|
10 |
Material Type: Article
|
LE CONCEPT DE REPRÉSENTATIONS PROFESSIONNELLES : L'EXEMPLE DES PRÉCEPTRICES SAGES!FEMMESMcGill journal of education, 2022-10, Vol.57 (3), p.295-305 [Peer Reviewed Journal]Copyright McGill Journal of Education Fall 2022 ;EISSN: 1916-0666Full text available |
|
11 |
Material Type: Article
|
P136 Comparison of obstetric outcomes in two consecutive pregnancies in women with renal and non-renal systemic lupus erythematosus – A retrospective single-centre cohort studyLupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A143-A144 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.190Full text available |
|
12 |
Material Type: Article
|
PO.2.39 Long term follow up of patients with primary obstetric antiphospholipid syndromeLupus science & medicine, 2022-10, Vol.9 (Suppl 2), p.A43-A44 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-elm2022.69Full text available |
|
13 |
Material Type: Article
|
PO.2.40 High expression of CD11c+Tbet+ B cell in triple APL positive primary obstetric antiphospholipid syndrome patientsLupus science & medicine, 2022-10, Vol.9 (Suppl 2), p.A44-A44 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-elm2022.70Full text available |
|
14 |
Material Type: Article
|
An overview of long non-coding RNAs in ovarian cancersOncotarget, 2016-07, Vol.7 (28), p.44719-44734Distributed under a Creative Commons Attribution 4.0 International License ;Copyright: © 2016 Meryet-Figuière et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.8089 ;PMID: 26992233Full text available |
|
15 |
Material Type: Article
|
The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophagesOncotarget, 2017-11, Vol.8 (59), p.99950-99965Attribution ;Copyright: © 2017 Bougherara et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.21556 ;PMID: 29245952Full text available |
|
16 |
Material Type: Article
|
18 Management of pregnancy in SLE and APSLupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A9-A10 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.18Full text available |
|
17 |
Material Type: Article
|
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in ChinaLupus science & medicine, 2023-08, Vol.10 (2), p.e000924 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-000924 ;PMID: 37607781Full text available |
|
18 |
Material Type: Article
|
Dietary Practice and Associated Factors among Pregnant Women in Misha Woreda, South Ethiopia: A Community-Based Cross-Sectional StudyJournal of nutrition and metabolism, 2020-09, Vol.2020, p.5091318-8 [Peer Reviewed Journal]Copyright © 2020 Lonsako Abute et al. ;COPYRIGHT 2020 Hindawi Limited ;Copyright © 2020 Lonsako Abute et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2020 Lonsako Abute et al. 2020 ;ISSN: 2090-0724 ;EISSN: 2090-0732 ;DOI: 10.1155/2020/5091318 ;PMID: 33062324Full text available |
|
19 |
Material Type: Article
|
Risk factors of first thrombosis in obstetric antiphospholipid syndromeLupus science & medicine, 2024-01, Vol.11 (1), p.e001044 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-001044 ;PMID: 38176700Full text available |
|
20 |
Material Type: Article
|
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancerOncotarget, 2017-12, Vol.8 (62), p.105356-105371Attribution ;Copyright: © 2017 Vattai et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.22187 ;PMID: 29285256Full text available |